Drug profile · INN
chlortetracycline hydrochloride
AUREOMYCIN
chlortetracycline hydrochloride (AUREOMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — chlortetracycline hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
chlortetracycline hydrochloride (AUREOMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is chlortetracycline hydrochloride?
chlortetracycline hydrochloride (AUREOMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for chlortetracycline hydrochloride?
AUREOMYCIN is a marketed brand name for chlortetracycline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlortetracycline hydrochloride?
chlortetracycline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.